Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00705523Phase 2Completed
Phase 2, randomised, double-blind trial in alcohol dependence comparing Varenicline with Placebo (2 arms). Primary endpoint: Rate of Heavy Drinking Days Per Week. Started Jun 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00705523.